What is this medicine used for?
FDA-approved uses
- Major depressive disorder — Adults. The US Remeron and Remeron SolTab labels approve adult major depression; pediatric approval is not established.Oral tablets; Orally disintegrating tablets.
Other uses (off-label)
Off-label means a medicine is prescribed for a use, age group or form that is not included in its FDA approval.
- Insomnia — Adults. Use for insomnia is outside the FDA depression indication. A randomized primary-care study found a short-term benefit at six weeks without a sustained advantage at later assessments. This is not a recommendation for routine or long-term use.Oral tablets.
What should I expect?
Antidepressant benefit may take several weeks or longer. Sleepiness can appear before mood improves; review sleep, appetite, mood, and daytime function as separate parts of your response.
Agree on a follow-up plan when treatment starts. Contact the prescriber if symptoms worsen, side effects disrupt daily life, or there is no useful improvement by the planned review; do not change the dose yourself.
How do I take it safely?
Take the prescribed dose once daily, usually in the evening before sleep. Do not drive or do hazardous work until you know its effect on alertness.
For SolTab, peel the blister with dry hands and place the whole tablet on the tongue immediately. Do not split, crush, chew, or save it outside the blister. It contains phenylalanine, which matters for phenylketonuria.
MAOIs without at least 14 days of separation in either direction. Known hypersensitivity to mirtazapine or the product ingredients.
Review falls, weight gain, blood fats, low sodium, and heart-rhythm risks. Kidney or liver impairment may change the prescribing plan.
Other serotonergic medicines, including SSRIs, SNRIs, some opioids, lithium, buspirone and St John’s wort, can increase serotonin-syndromeSerotonin syndromeSerotonin syndrome (also called serotonin toxicity) is a potentially life-threatening drug reaction caused by excessive serotonin activity in the nervous system.It can develop soon after starting or increasing a serotonin-affecting medicine, or combining it with another medicine or substance that affects serotonin.Possible signs include agitation or confusion, sweating, fever, diarrhea, shaking, and stiff or twitching muscles.Seek urgent medical help if you suspect serotonin syndrome. Severe symptoms, such as a high fever, seizures, or loss of consciousness, need emergency care. risk. MAOI combinations are prohibited by the label.
Strong CYP3A inducers such as carbamazepine or phenytoin can lower levels; strong CYP3A inhibitors can raise them. Cimetidine can also raise exposure. Starting or stopping an interacting drug may require dose reassessment.
Alcohol and benzodiazepines add to cognitive and motor impairment and should be avoided with the branded products according to the label. Medicines that prolong the QT interval increase cardiac concerns. Warfarin requires INR monitoring with concomitant use.
Available observational pregnancy experience has not reliably identified a drug-associated increase in major birth defects or miscarriage, but this does not prove absence of every risk. Untreated depression also matters; discuss an individualized plan rather than abruptly stopping.
Mirtazapine enters breast milk at low reported levels. Discuss breastfeeding benefits, maternal need and possible infant effects with the treating clinician. The US products are not approved for children; pediatric depression studies did not establish effectiveness and showed substantial weight gain. Older adults need particular caution with sedation, confusion, low sodium and reduced clearance.
A gradual reduction is recommended rather than abrupt stopping when possible. Dizziness, abnormal dreams, sensory changes, agitation, anxiety, nausea, sweating and other discontinuation symptoms may occur. A clinician can individualize the plan; this article does not provide a taper schedule.
For a missed dose, the Medication Guide advises taking it when remembered unless the next dose is nearly due; then skip it. Do not take two doses together. Ask a pharmacist if the timing is uncertain.
What side effects should I know about?
- Sleepiness and impaired alertness.
- Increased appetite, weight gain, dry mouth and constipation.
- Dizziness; cholesterol or triglyceride elevations may also occur.
Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.
Looking for more detailed information?
The official medicine information lists more side effects, safety advice and product instructions.
- View FDA Prescribing Information (PDF) (opens in a new tab)Remeron tablets and Remeron SolTab
Which warning signs need help?
- Fever with agitation or confusion, sweating, diarrhea, muscle rigidity or twitching, and a fast heartbeat can be serotonin syndromeSerotonin syndromeSerotonin syndrome (also called serotonin toxicity) is a potentially life-threatening drug reaction caused by excessive serotonin activity in the nervous system.It can develop soon after starting or increasing a serotonin-affecting medicine, or combining it with another medicine or substance that affects serotonin.Possible signs include agitation or confusion, sweating, fever, diarrhea, shaking, and stiff or twitching muscles.Seek urgent medical help if you suspect serotonin syndrome. Severe symptoms, such as a high fever, seizures, or loss of consciousness, need emergency care.. Seek urgent medical care.
- Fever, sore throat or mouth sores need prompt assessment for infection and possible low white-blood-cell counts.
- Rash with fever or swollen glands, blistering skin, severe allergy, seizures, fainting with palpitations or severe confusion need urgent care.
- New suicidal thoughts or marked mood elevation requires prompt help.
- Get emergency help for trouble breathing, collapse, a seizure, or severe or rapidly worsening symptoms. If thoughts of self-harm put you in immediate danger, seek emergency care now.
What else should I know to stay safe?
- Do not use after an allergy to mirtazapine or its ingredients, or with MAO inhibitors without at least 14 days of separation in either direction. Other serotonin-affecting medicines, some antifungals and seizure medicines, cimetidine, and heart-rhythm medicines need review; warfarin requires monitoring.
- Alcohol and benzodiazepines can worsen impairment and should be avoided with these products according to the label. Review falls, weight, blood fats, low sodium, heart-rhythm risk, and kidney or liver impairment. SolTab contains phenylalanine, which matters for phenylketonuria. Plan gradual stopping with the prescriber.
- Discuss pregnancy and breastfeeding. Limited reassuring pregnancy observations do not establish absence of every risk, and untreated depression matters. Mirtazapine enters milk. These products are not approved for children; older adults need particular attention to sedation, confusion, and low sodium. Pediatric depression trials did not establish effectiveness and found substantial weight gain more often than with placebo. If off-label treatment is considered, discuss the rationale and follow-up for weight, daytime sleepiness and mood.
Urgent help and crisis support · Emergency & Crisis Resources (US)
What can help day to day?
- A dissolving tablet can help with administration, but it does not remove the medicine’s usual risks. Keep it in its blister until use and handle it with dry hands.
- Appetite and weight changes deserve the same attention as mood improvement. Mention them early so they can be included in the treatment review.
How does it work?
Mirtazapine changes nerve-cell communication by blocking several kinds of receptors, the proteins that respond to chemical messages. Some of these receptors normally act as brakes on the release of messengers, while others influence wakefulness and other functions. Its antidepressant effect may involve these changes, but no single receptor action fully explains the benefit.
How was this medicine developed?
The FDA approved Remeron in 1996. Mirtazapine added an antidepressant with a different pattern of receptor effects from SSRIs. A dissolving tablet later provided another way to take the same medicine, with its own handling instructions.
How do I say the name?
Mirtazapine: mir-TAZ-uh-peen. Capital letters show the stressed syllable.
Medicine forms and official information
Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.
Choose a formulation
Oral tablets
Conventional Remeron tablets: current branded strengths 15 and 30 mg; generic products may differ.
Orally disintegrating tablets
SolTab: use immediately from blister; do not split; contains phenylalanine.
Sources and References
Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.
- DREAMING randomized trial: mirtazapine for insomnia, short-term benefit and longer-term limitations
- DailyMed: Remeron tablets and Remeron SolTab
- Mirtazapine: patient information and pronunciation
- Drugs@FDA: Remeron approval history and tablet products
- Effectiveness of low-dose amitriptyline and mirtazapine in patients with insomnia disorder and sleep maintenance problems: a randomised, double-blind, placebo-controlled trial in general practice (DREAMING)
- FDA: Remeron and Remeron SolTab prescribing information
- Mirtazapine Orally Disintegrating Tablets: Package Insert / Prescribing Info / MOA
- Drugs@FDA: Remeron SolTab approval history and products
- FDA: Zoloft prescribing information and Medication Guide
- FDA: Lexapro prescribing information and Medication Guide
- FDA: Wellbutrin XL prescribing information and Medication Guide
- NIH: What Is a Neurotransmitter?
- PubChem: Mirtazapine parent compound and verified 2D record
- ISMP List of Confused Drug Names
- Serotonin syndrome: MedlinePlus Medical Encyclopedia
- Monitoring a person during and after antidepressant switching – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice
Giving medicine safely to children: family guide (PDF, 3 pages)

